<DOC>
	<DOCNO>NCT02034799</DOCNO>
	<brief_summary>The objective study observe clinical utility performance Bioseal use adjunct hemostasis versus Standard Care ( SoC ) elective meningioma surgery .</brief_summary>
	<brief_title>Phase IV Bioseal Study Brain Tumor Surgery</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Meningioma</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>Subjects 18 75 year age Undergoing elective meningioma surgery tumor cavity Presence appropriate Target Bleeding Site ( TBS ) identify intraoperatively surgeon require adjunct achieve hemostasis Able willing comply procedure require protocol Signed date write informed consent prior study related procedure . Subjects undergoing emergency surgery Subjects intraoperative finding may preclude conduct study procedure Intended use Fibrin Sealants ( include autologous Fibrin Sealants ) Bioseal TBS Subjects know intolerance blood product one component study product unwilling receive blood product Subjects history traumatic head injury Female subject know breastfeed pregnant intend become pregnant clinical study period The subject , opinion investigator , would suitable participation study Subjects participate another trial within 30 day prior planned start treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>